Systematic Review and Meta-Analysis of the Incidence of Chronic Kidney Disease After Pediatric Critical Illness

被引:0
|
作者
Akinkugbe, Olugbenga [1 ,2 ,3 ]
Marchetto, Luca [4 ]
Martin, Isaac [3 ,5 ]
Chia, Shin Hann [6 ]
机构
[1] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada
[2] Univ Toronto, Temerty Fac Med, Interdept Div Crit Care Med, Toronto, ON, Canada
[3] Univ Toronto, Temerty Fac Med, Dept Paediat, Toronto, ON, Canada
[4] Univ Hosp Padua, Dept Womens & Childrens Hlth, Pediat Intens Care Unit, Padua, Italy
[5] Hosp Sick Children, Dept Paediat, Toronto, ON, Canada
[6] James Cook Univ Hosp, South Tees NHS Fdn Trust, Dept Cardiothorac Anaesthesia, Middlesbrough, England
关键词
critical care outcomes; chronic kidney disease; pediatric chronic kidney disease; post-pediatric intensive care unit; CHILDREN; INJURY; EPIDEMIOLOGY; PREVALENCE; PREDICTION; OUTCOMES;
D O I
10.1097/CCE.0000000000001129
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
OBJECTIVE:Survivors of pediatric critical illnesses are at risk of significant long-term organ sequelae. Chronic kidney disease (CKD) is a complication of critical illness (and ICU interventions) associated with growth impairment, cardiovascular disease, and early death. Our objective was to synthesize the evidence on the incidence of CKD among survivors of pediatric critical illness.DATA SOURCES:MEDLINE, Embase, Cumulative Index to Nursing and Allied Health Literature, and Cochrane Register of Controlled Trials from inception to February 2024.STUDY SELECTION:Observational studies reporting the incidence of de novo CKD among survivors of pediatric critical illness.DATA EXTRACTION:Two reviewers independently extracted data on study design, setting, population, demographics, diagnostic criteria, and outcome.DATA SYNTHESIS:Meta-analysis was used to describe the incidence of CKD among survivors, risk of bias (RoB) assessed using the Joanna Briggs Institute Tool, and strength and reliability of evidence assessed with GRADE (Grading of Recommendations, Assessment, Development, and Evaluations). CKD was quantified as an estimated glomerular filtration rate (eGFR) less than 90 mL/min/1.73 m2 (outcome 1), eGFR less than 60 mL/min/1.73 m2 (outcome 2), and end-stage renal disease (ESRD) as eGFR less than 15 mL/min per 1.73 m2 (outcome 3). Twelve studies (3642 patients) met selection criteria and reported at least one measure of CKD. The median duration of follow-up was 2, 3.6, and 5 years, respectively, for outcomes 1, 2, and 3. For each threshold, the pooled estimate of CKD incidence was 24% (95% CI, 16-32%) for eGFR less than 90, 14% (95% CI, 6-23%) less than 60, and 4% (95% CI, 0-7%) for ESRD. The overall quality assessment indicated a moderate RoB.CONCLUSIONS:Among a heterogenous population of pediatric critical illness survivors, an important minority of survivors developed CKD or ESRD. This study highlights the importance of diagnostic criteria for reporting, a greater focus on postcritical care surveillance and follow-up to identify those with CKD. Further study would facilitate the delineation of high-risk groups and strategies for improved outcomes.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis
    Al Khalaf, Sukainah
    Bodunde, Elizabeth
    Maher, Gillian M.
    O'Reilly, Eilis J.
    McCarthy, Fergus P.
    O'Shaughnessy, Michelle M.
    O'Neill, Sinead M.
    Khashan, Ali S.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2022, 226 (05) : 656 - +
  • [42] N-acetylcysteine for chronic kidney disease: a systematic review and meta-analysis
    Ye, Minyuan
    Lin, Weiyuan
    Zheng, Jing
    Lin, Shaopeng
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2021, 13 (04): : 2472 - 2485
  • [43] SES, Chronic Kidney Disease, and Race in the US: A Systematic Review and Meta-analysis
    Vart, Priya
    van Zon, Sander K. R.
    Gansevoort, Ron T.
    Bultmann, Ute
    Reijneveld, Sijmen A.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2017, 53 (05) : 730 - 739
  • [44] High circulating endocan in chronic kidney disease? A systematic review and meta-analysis
    Khalaji, Amirmohammad
    Behnoush, Amir Hossein
    Kia, Yasmin Mohtasham
    Alehossein, Parsa
    Bahiraie, Pegah
    PLOS ONE, 2023, 18 (08):
  • [45] Coronary flow abnormalities in chronic kidney disease: A systematic review and meta-analysis
    Jain, Vardhmaan
    Gupta, Kartik
    Bhatia, Kirtipal
    Rajapreyar, Indranee
    Singh, Amitoj
    Zhou, Wunan
    Klein, Allan
    Nanda, Navin C.
    Prabhu, Sumanth D.
    Bajaj, Navkaranbir S.
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2022, 39 (11): : 1382 - 1390
  • [46] Effect of pentoxifylline in proteinuric chronic kidney disease: a systematic review and meta-analysis
    Xiangpin Jiang
    Shengguo Zhou
    Jing Yao
    Xianglei Kong
    Meiyu Cui
    Journal of Nephrology, 2016, 29 : 653 - 662
  • [47] Efficacy of Probiotics Supplementation On Chronic Kidney Disease: a Systematic Review and Meta-Analysis
    Jia, Linpei
    Jia, Qiang
    Yang, Jingyan
    Jia, Rufu
    Zhang, Hongliang
    KIDNEY & BLOOD PRESSURE RESEARCH, 2018, 43 (05): : 1623 - 1635
  • [48] Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis
    Kaze, Arnaud D.
    Ilori, Titilayo
    Jaar, Bernard G.
    Echouffo-Tcheugui, Justin B.
    BMC NEPHROLOGY, 2018, 19
  • [49] A Systematic Review and Meta-Analysis of Pharmacogenetic Studies in Patients with Chronic Kidney Disease
    Tziastoudi, Maria
    Pissas, Georgios
    Raptis, Georgios
    Cholevas, Christos
    Eleftheriadis, Theodoros
    Dounousi, Evangelia
    Stefanidis, Ioannis
    Theoharides, Theoharis C.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (09)
  • [50] Intravenous thrombolysis in patients with chronic kidney disease A systematic review and meta-analysis
    Malhotra, Konark
    Katsanos, Aristeidis H.
    Goyal, Nitin
    Tayal, Ashis
    Gensicke, Henrik
    Mitsias, Panayiotis D.
    De Marchis, Gian Marco
    Berge, Eivind
    Alexandrov, Anne W.
    Alexandrov, Andrei V.
    Tsivgoulis, Georgios
    NEUROLOGY, 2020, 95 (02) : E121 - E130